Climb Bio, Inc., 2026-05-04
An SEC Form D private-offering notice from Wellesley Hills, MA, a $110,076,289 filer-stated offering target in Biotech. Filed 2026-05-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical stage biotechnology company developing monoclonal antibody therapies for immune mediated diseases, including budoprutug for B cell mediated conditions.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- TN I FF LLC, 2026-05-05, $2.5M, Boston, MA
- Mentat Biotechnology, Corp., 2026-05-04, $10K, Daly City, CA
- Inflammasome Therapeutics, Inc., 2026-05-04, $13.2M, Newton, MA
- PharmassetX Inc., 2026-05-04, $6M, Louisville, KY
- JuliaHub, Inc., 2026-05-04, $69.9M, Boston, MA
- Enveric Biosciences, Inc., 2026-05-04, $5M, Cambridge, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.